Dexcom Inc DXCM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:50 PM EDT
113.00quote price arrow up+1.06 (+0.95%)
Volume
319,175
Close
111.94quote price arrow down-0.19 (-0.17%)
Volume
3,295,150
52 week range
74.75 - 142.00
Loading...
  • Open111.97
  • Day High113.08
  • Day Low110.00
  • Prev Close112.13
  • 52 Week High142.00
  • 52 Week High Date03/26/24
  • 52 Week Low74.75
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap44.517B
  • Shares Out397.68M
  • 10 Day Average Volume2.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-9.79

KEY STATS

  • Open111.97
  • Day High113.08
  • Day Low110.00
  • Prev Close112.13
  • 52 Week High142.00
  • 52 Week High Date03/26/24
  • 52 Week Low74.75
  • 52 Week Low Date10/13/23
  • Market Cap44.517B
  • Shares Out397.68M
  • 10 Day Average Volume2.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-9.79

RATIOS/PROFITABILITY

  • EPS (TTM)1.52
  • P/E (TTM)73.78
  • Fwd P/E (NTM)59.48
  • EBITDA (TTM)865.10M
  • ROE (TTM)28.54%
  • Revenue (TTM)3.802B
  • Gross Margin (TTM)63.25%
  • Net Margin (TTM)16.82%
  • Debt To Equity (MRQ)110.98%

EVENTS

  • Earnings Date07/25/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by...
Kevin Sayer
Chairperson of the Board, President, Chief Executive Officer
Jacob Leach
Executive Vice President, Chief Operating Officer
Jereme Sylvain
Chief Financial Officer, Executive Vice President
Michael Brown
Executive Vice President, Chief Legal Officer
Matthew Dolan
Executive Vice President - Strategy, Corporate Development and Dexcom Labs
Address
6340 Sequence Dr
San Diego, CA
92121-4356
United States

Top Peers

SYMBOLLASTCHG%CHG
IDXX
IDEXX Laboratories Inc
471.34+0.93+0.20%
RMD
Resmed Inc
206.20-3.33-1.59%
A
Agilent Technologies Inc
134.16+3.51+2.69%
HOLX
Hologic Inc
78.34+0.24+0.31%
STE
STERIS plc
231.72+0.02+0.01%